Increased Expression of Cyclooxygenases and Peroxisome Proliferator-Activated Receptor-γ in Alzheimer's Disease Brains
- 1 January 1999
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 254 (3), 582-586
- https://doi.org/10.1006/bbrc.1998.9981
Abstract
No abstract availableFunding Information
- Alexander von Humboldt-Stiftung
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 28 references indexed in Scilit:
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- Maturational Regulation and Regional Induction of Cyclooxygenase-2 in Rat Brain: Implications for Alzheimer's DiseaseExperimental Neurology, 1997
- Induction of cyclo-oxygenase 2 in brains of patients with Downʼs syndrome and dementia of Alzheimer typeNeuroReport, 1997
- Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory DrugsJournal of Biological Chemistry, 1997
- Expression and Regulation of Cyclooxygenase‐2 in Rat MicrogliaEuropean Journal of Biochemistry, 1997
- Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's diseaseNeurobiology of Aging, 1996
- Reactive Glia Express Cytosolic Phospholipase A2 After Transient Global Forebrain Ischemia in the RatStroke, 1996
- Activation of Phospholipase A2 by Amyloid β-Peptides in VitroBiochemistry, 1996
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγCell, 1995
- Alteration of Phospholipase C‐δ Protein Level and Specific Activity in Alzheimer's DiseaseJournal of Neurochemistry, 1995